Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qilong capsules
- Development stage
- Unknown
- Lead developer
- Jining Huaneng Pharmaceutical Factory
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qilong capsules (QLC) is a Traditional Chinese Medicine (TCM) formulation primarily used in China for the treatment of ischemic stroke, specifically for patients presenting with the Qi deficiency and blood stasis syndrome. The product is manufactured by Jining Huaneng Pharmaceutical Factory and has been the subject of clinical research by the China Academy of Chinese Medical Sciences. The formulation typically contains a combination of herbal and animal-derived ingredients, including *Astragalus membranaceus* (Huangqi) and *Pheretima* (Dilong). Pharmacologically, Qilong capsules are reported to exert neuroprotective effects, inhibit platelet aggregation, improve cerebral microcirculation, and modulate inflammatory responses. It is often used as an adjuvant therapy to standard modern medical treatments to reduce the risk of stroke recurrence and improve functional recovery in patients with large-artery atherosclerosis or small-artery occlusion subtypes of ischemic stroke.
- Brand names
- Qilong capsules
- Other names
- Qilong Jiaonang
02
Targets
CASP3 (Caspase-3)P2Y (P2Y receptors)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Qilong capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qilong capsules.